termsTerm
PSA (prostate-specific antigen)
A blood protein made by the prostate; raised levels prompt further tests, and falling levels show treatment is working.
Screening test with proven mortality reduction (ERSPC ~20% at 16 years) but substantial overdiagnosis; now paired with MRI and risk-adapted intervals. In treated disease, PSA kinetics (doubling time, PSA50/PSA90 response, nadir) are the everyday response measure, though not a validated surrogate for survival in mCRPC.
Biomarkers: what this kind of term is about · animated schematic, not to scale
Category
Biomarkers
Pages like this
not linked directly; found by shared links- TrialEMBARK
- InstitutionMovember
Shares Prostate Cancer Foundation (PCF), Overdiagnosis and false alarms, Prostate cancer.
- IdeaTest whether calling Gleason 6 'not cancer' changes what men choose
- IdeaModern autopsy studies to measure how much silent cancer people carry
- ProductFluciclovine F-18
- IdeaCertified decision aids required for every preference-sensitive cancer decision
- ProductXaluritamig
Shares PSA50 / PSA90 response, Prostate cancer.
- TrialTheraP (ANZUP 1603)
Shares PSA50 / PSA90 response, Prostate cancer.